SVB Leerink reiterated coverage on Amarin Corp with a new price target

2/16/22 5:16:57 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

SVB Leerink reiterated coverage of Amarin Corp with a rating of Outperform and set a new price target of $10.00 from $11.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AMRN

Date	Price Target	Rating	Analyst
11/20/2023		Underweight	JP Morgan
10/25/2023	$3.00 → $1.00	Buy → Hold	Jefferies
1/6/2023	$1.30 → $3.00	Hold → Buy	Jefferies
5/6/2022		Neutral → Underweight	JP Morgan
5/5/2022	$10.00 → $3.00	Outperform → Mkt Perform	SVB Leerink
5/5/2022	$10.00 → $3.00	Buy → Neutral	H.C. Wainwright
5/4/2022		Outperform → Market Perform	Northland Capital
2/16/2022	$11.00 → $10.00	Outperform	SVB Leerink